Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Autoimmune Disorders

Free Subscription 02.05.2022 1 Ann Neurol 3 BMC Neurol 2 J Autoimmun 1 J Clin Endocrinol Metab 1 J Immunol 1 J Nephrol 2 J Neuroimmunol 1 J Neurol 2 J Pediatr 1 Lancet 2 Lancet Neurol 4 Mult Scler 2 Neurologia (Engl Ed) 6 Neurology 1 PLoS Med 7 PLoS One 2 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. MANDEL-BREHM C, Benson LA, Tran B, Kung AF, et al
   ZSCAN1 autoantibodies are associated with pediatric paraneoplastic ROHHAD.
   Ann Neurol. 2022 Apr 25. doi: 10.1002/ana.26380.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. YU Y, Liu JL, Tian DS
   Anti-N-methyl-D-aspartate receptor encephalitis associated with chronic myelogenous leukemia, causality or coincidence? A case report.
   BMC Neurol. 2022;22:153.
   PubMed         Abstract available
   
   
3. PATEL P, Shah D, Jani C, Shah J, et al
   Outcomes of patients presenting with Guillain-Barre Syndrome at a tertiary care center in India.
   BMC Neurol. 2022;22:151.
   PubMed         Abstract available
   
   
4. BEITOLLAHI M, Forouzi MA, Tirgari B, Jahani Y, et al
   Fatigue, stigma, and mood in patients with multiple sclerosis: effectiveness of guided imagery.
   BMC Neurol. 2022;22:152.
   PubMed         Abstract available
   
   

   
   J Autoimmun

5. MELDERIS S, Warkotsch MT, Dang J, Hagenstein J, et al
   The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of pathogenic CD4(+) T helper cell responses.
   J Autoimmun. 2022;129:102829.
   PubMed         Abstract available
   
   
6. LI X, Gao L, Tong X, Chan VKY, et al
   Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
   J Autoimmun. 2022;130:102830.
   PubMed         Abstract available
   
   

   
   J Clin Endocrinol Metab

7. WEBB-ROBERTSON BM, Nakayasu ES, Frohnert BI, Bramer LM, et al
   Integration of Infant Metabolite, Genetic and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by 6 Years of Age.
   J Clin Endocrinol Metab. 2022 Apr 25. pii: 6573923. doi: 10.1210.
   PubMed         Abstract available
   
   

   
   J Immunol

8. KUMAR P, Balakrishnan S, Surendra Lele S, Setty S, et al
   Restoration of Follicular T-Regulatory/Helper Cell Balance by OX40L-JAG1 Cotreatment Suppresses Lupus Nephritis in NZBWF1/j Mice.
   J Immunol. 2022 Apr 25. pii: jimmunol.2200057. doi: 10.4049/jimmunol.2200057.
   PubMed         Abstract available
   
   

   
   J Nephrol

9. LIU M, Yu X, Wang S, Qin A, et al
   Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.
   J Nephrol. 2022 Apr 23. pii: 10.1007/s40620-022-01317.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

10. ODA F, Uzawa A, Ozawa Y, Yasuda M, et al
    Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy.
    J Neuroimmunol. 2022;365:577833.
    PubMed         Abstract available
    
    
11. KYLLESBECH C, Trier N, Slibinskas R, Ciplys E, et al
    Virus-specific antibody indices may supplement the total IgG index in diagnostics of multiple sclerosis.
    J Neuroimmunol. 2022;367:577868.
    PubMed         Abstract available
    
    

    
    J Neurol

12. HVID LG, Stenager E, Dalgas U
    Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study.
    J Neurol. 2022 Apr 28. pii: 10.1007/s00415-022-11134.
    PubMed         Abstract available
    
    

    
    J Pediatr

13. BRIX N, Amstrup J, Norgaard M, Hagstrom S, et al
    Musculoskeletal Diagnoses before Cancer in Children: A Danish Registry-Based Cohort Study.
    J Pediatr. 2022;242:32-38.
    PubMed         Abstract available
    
    
14. THOREBY CV, Walsh BH
    The Periorbital Rash of Neonatal Lupus.
    J Pediatr. 2021 Dec 2. pii: S0022-3476(21)01162.
    PubMed        
    
    

    
    Lancet

15. SETHI S, De Vriese AS, Fervenza FC
    Acute glomerulonephritis.
    Lancet. 2022;399:1646-1663.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

16. FOLEY JF, Defer G, Ryerson LZ, Cohen JA, et al
    Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
    Lancet Neurol. 2022 Apr 25. pii: S1474-4422(22)00143.
    PubMed         Abstract available
    
    
17. HELLWIG K
    Natalizumab for multiple sclerosis: the dilemma of NOVA.
    Lancet Neurol. 2022 Apr 25. pii: S1474-4422(22)00170.
    PubMed        
    
    

    
    Mult Scler

18. SPRENGER T, Kappos L, Sormani MP, Miller AE, et al
    Effects of teriflunomide treatment on cognitive performance and brain volume in patients with relapsing multiple sclerosis: Post hoc analysis of the TEMSO core and extension studies.
    Mult Scler. 2022 Apr 29:13524585221089534. doi: 10.1177/13524585221089534.
    PubMed         Abstract available
    
    
19. DEGRAEVE B, Sequeira H, Mecheri H, Lenne B, et al
    Corpus callosum damage to account for cognitive, affective, and social-cognitive dysfunctions in multiple sclerosis: A model of callosal disconnection syndrome?
    Mult Scler. 2022 Apr 27:13524585221091067. doi: 10.1177/13524585221091067.
    PubMed         Abstract available
    
    
20. MANZANO GS, Rice DR, Klawiter EC, Matiello M, et al
    Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study.
    Mult Scler. 2022 Apr 27:13524585221092309. doi: 10.1177/13524585221092309.
    PubMed         Abstract available
    
    
21. ZABALZA A, Arrambide G, Otero-Romero S, Pappolla A, et al
    Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
    Mult Scler. 2022 Apr 27:13524585221089540. doi: 10.1177/13524585221089540.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

22. CARREON GUARNIZO E, Hernandez Clares R, Castillo Trivino T, Meca Lallana V, et al
    Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders.
    Neurologia (Engl Ed). 2022;37:178-183.
    PubMed         Abstract available
    
    
23. LEON RUIZ M, Sospedra M, Arce Arce S, Tejeiro-Martinez J, et al
    Current evidence on the potential therapeutic applications of transcranial magnetic stimulation in multiple sclerosis: a systematic review of the literature.
    Neurologia (Engl Ed). 2022;37:199-215.
    PubMed         Abstract available
    
    

    
    Neurology

24. YANG JH, Graves JS
    Cancer Screening in Patients With Multiple Sclerosis: Are We Doing Enough?
    Neurology. 2022 Apr 28. pii: WNL.0000000000200366.
    PubMed        
    
    
25. HAMILTON R, Ciccarelli O
    Multiple Sclerosis Incidence in Black Patients: It's Time to Do Away With a Racial Medical Myth.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200309.
    PubMed        
    
    
26. LANGER-GOULD AM, Gonzales EG, Smith JB, Li BH, et al
    Racial and Ethnic Disparities in Multiple Sclerosis Prevalence.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200151.
    PubMed         Abstract available
    
    
27. GROOME PA, Webber C, Maxwell CJ, McClintock C, et al
    Multiple Sclerosis and the Cancer Diagnosis: Diagnostic Route, Cancer Stage, and the Diagnostic Interval in Breast and Colorectal Cancer.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200163.
    PubMed         Abstract available
    
    
28. ROTSTEIN D, Solomon JM, Sormani MP, Montalban X, et al
    Association of No Evidence of Disease Activity With No Long-term Disability Progression in Multiple Sclerosis: A Systematic Review and Meta-analysis.
    Neurology. 2022 Apr 26. pii: WNL.0000000000200549.
    PubMed         Abstract available
    
    
29. OKAI AF, Howard AM, Williams MJ, Brink JD, et al
    Advancing Care and Outcomes for African American Patients With Multiple Sclerosis.
    Neurology. 2022 Apr 25. pii: WNL.0000000000200791.
    PubMed         Abstract available
    
    

    
    PLoS Med

30. SPANGMOSE AL, Skipper N, Knorr S, Wullum Gundersen T, et al
    School performance in Danish children exposed to maternal type 1 diabetes in utero: A nationwide retrospective cohort study.
    PLoS Med. 2022;19:e1003977.
    PubMed         Abstract available
    
    

    
    PLoS One

31. SHOBEIRI P, Karimi A, Momtazmanesh S, Teixeira AL, et al
    Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic review and meta-analysis of exercise intervention trials.
    PLoS One. 2022;17:e0264557.
    PubMed         Abstract available
    
    
32. LIN X, Liu Y, Chen Y, Huang X, et al
    Prediction of prognosis in immunoglobulin a nephropathy patients with focal crescent by machine learning.
    PLoS One. 2022;17:e0265017.
    PubMed         Abstract available
    
    
33. ZRUBKA Z, Kincses A, Ferenci T, Kovacs L, et al
    Comparing actuarial and subjective healthy life expectancy estimates: A cross-sectional survey among the general population in Hungary.
    PLoS One. 2022;17:e0264708.
    PubMed         Abstract available
    
    
34. FICHTNER ML, Hoarty MD, Vadysirisack DD, Munro-Sheldon B, et al
    Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
    PLoS One. 2022;17:e0264489.
    PubMed         Abstract available
    
    
35. ROVO A, Cantoni N, Samii K, Rufer A, et al
    Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium.
    PLoS One. 2022;17:e0267342.
    PubMed         Abstract available
    
    
36. BIERNACKI T, Sandi D, Fuvesi J, Fricska-Nagy Z, et al
    The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
    PLoS One. 2022;17:e0267346.
    PubMed         Abstract available
    
    
37. YADAV M, Ali S, Shrode RL, Shahi SK, et al
    Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
    PLoS One. 2022;17:e0264556.
    PubMed         Abstract available
    
    

    
    Thyroid

38. 
    Correction to: Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy by Vannucchi, et al. Thyroid 2021;31(5):821-828; doi: 10.1089/thy.2020.0269.
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2020.0269.
    PubMed        
    
    
39. HUANG Y, Wu Y, Zhang S, Lu Y, et al
    Immunophenotype of lacrimal glands in Graves orbitopathy: Implications for the pathogenesis of Th1 and Th17 immunity.
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2021.0671.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: